Actively Recruiting
Study of Silent Atrial Fibrillation in People Aged 50 and Older With Silent Brain Ischemic Lesions Using Long-Term Heart Monitoring
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2024-11-14
150
Participants Needed
8
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the role of Arterial Fibrillation AF in patients with Silent Brain Infarction SBI, a condition where brain lesions occur without obvious symptoms. While AF is a well-known cause of cryptogenic Acute Ischemic Stroke AIS, its impact on SBI formation is less clear and requires further study. The main goal is to compare the incidence of AF diagnosis over 24 months between patients with SBI and those with cryptogenic AIS to better understand AFs role in these silent brain lesions. Participants aged 65 or older, or those 50 and older with specific heart-related markers, who have clinically silent ischemic brain lesions identified by MRI, will receive a subcutaneous cardiac monitor implant called Reveal LINQ. This device continuously tracks heart rhythms and transmits data to physicians via the Medtronic MyCareLink system. The study monitors for various heart rhythm irregularities, including episodes of AF lasting 30 seconds or longer, and other significant arrhythmias. Relevant findings are reviewed within one week and communicated to patients and their doctors within two weeks. During the study, researchers will assess the cumulative incidence of AF diagnosis over 24 months and also measure times to first AF diagnosis, AF burden, stroke occurrence, mortality, and other heart-related conditions. Brain MRI scans may be repeated at 24 months if funding allows. Patients provide informed consent and undergo regular evaluations while their heart rhythm data is continuously monitored to help clarify AFs role in silent brain infarctions. The study aims to inform care strategies for SBI, potentially improving patient management.
CONDITIONS
Brief Title
Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions
Research Team
L
Laurent Roten, PD Dr. med.
T
Thomas Meinel, Dr. med.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here